The Center for Biomedical Technology has successfully developed extracorporeal liver support technologies. In this project new targets for extracorporeal liver support will be investigated. A spectrum of bile acids will be tested for their depletion from blood using adsorbent-based apheresis systems. Additionally, the influence of liver support systems on human serum albumins (HSA) regarding oxidized HSA-fractions and changes in albumin conformation will be evaluated. Furthermore, it will be tested whether the quantitative change of oxidized HSA can be used as biomarker to optimize treatment time in extracorporeal liver support.

Country of Lower Austria, EFRE
Fresenius Medical Care        






Duration 01/01/2016 - 31/12/2019
Funding Bundesländer (inkl. deren Stiftungen und Einrichtungen)
Program Technologieförderung NÖ

Department for Biomedical Research

Center for Biomedical Technology

Principle investigator for the project (University for Continuing Education Krems) Assoz. Prof. Dr. Jens Hartmann

Project Manager

Back to top